nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ORM1—saliva—attention deficit hyperactivity disorder	0.157	0.222	CbGeAlD
Vemurafenib—RAF1—forebrain—attention deficit hyperactivity disorder	0.0541	0.0767	CbGeAlD
Vemurafenib—BRAF—midbrain—attention deficit hyperactivity disorder	0.0536	0.076	CbGeAlD
Vemurafenib—RAF1—cardiovascular system—attention deficit hyperactivity disorder	0.0458	0.0649	CbGeAlD
Vemurafenib—BRAF—cerebellum—attention deficit hyperactivity disorder	0.0415	0.0588	CbGeAlD
Vemurafenib—RAF1—midbrain—attention deficit hyperactivity disorder	0.0357	0.0507	CbGeAlD
Vemurafenib—BRAF—brain—attention deficit hyperactivity disorder	0.0337	0.0478	CbGeAlD
Vemurafenib—RAF1—nervous system—attention deficit hyperactivity disorder	0.0294	0.0416	CbGeAlD
Vemurafenib—RAF1—central nervous system—attention deficit hyperactivity disorder	0.0283	0.0401	CbGeAlD
Vemurafenib—RAF1—cerebellum—attention deficit hyperactivity disorder	0.0277	0.0392	CbGeAlD
Vemurafenib—RAF1—brain—attention deficit hyperactivity disorder	0.0225	0.0318	CbGeAlD
Vemurafenib—ORM1—nervous system—attention deficit hyperactivity disorder	0.0203	0.0288	CbGeAlD
Vemurafenib—ORM1—central nervous system—attention deficit hyperactivity disorder	0.0195	0.0277	CbGeAlD
Vemurafenib—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.0153	0.0218	CbGeAlD
Vemurafenib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.0148	0.021	CbGeAlD
Vemurafenib—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.0138	0.0196	CbGeAlD
Vemurafenib—ALB—brain—attention deficit hyperactivity disorder	0.0136	0.0193	CbGeAlD
Vemurafenib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.0114	0.0162	CbGeAlD
Vemurafenib—ABCC1—brain—attention deficit hyperactivity disorder	0.0112	0.0159	CbGeAlD
Vemurafenib—ABCG2—brain—attention deficit hyperactivity disorder	0.00929	0.0132	CbGeAlD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00906	0.0308	CbGpPWpGaD
Vemurafenib—ABCG2—Fluoropyrimidine Activity—DPYD—attention deficit hyperactivity disorder	0.00875	0.0297	CbGpPWpGaD
Vemurafenib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00847	0.012	CbGeAlD
Vemurafenib—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00833	0.0118	CbGeAlD
Vemurafenib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00815	0.0116	CbGeAlD
Vemurafenib—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00802	0.0114	CbGeAlD
Vemurafenib—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00784	0.0111	CbGeAlD
Vemurafenib—RAF1—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—attention deficit hyperactivity disorder	0.00746	0.0253	CbGpPWpGaD
Vemurafenib—RAF1—FSH signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00695	0.0236	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00681	0.0231	CbGpPWpGaD
Vemurafenib—CYP2D6—brain—attention deficit hyperactivity disorder	0.00637	0.00903	CbGeAlD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRQ—attention deficit hyperactivity disorder	0.00627	0.0213	CbGpPWpGaD
Vemurafenib—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00604	0.0205	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—SNAP23—attention deficit hyperactivity disorder	0.0059	0.02	CbGpPWpGaD
Vemurafenib—RAF1—NCAM signaling for neurite out-growth—CACNB2—attention deficit hyperactivity disorder	0.00572	0.0194	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—GABRQ—attention deficit hyperactivity disorder	0.00558	0.0189	CbGpPWpGaD
Vemurafenib—RAF1—NCAM signaling for neurite out-growth—CACNA1C—attention deficit hyperactivity disorder	0.00523	0.0178	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00522	0.0177	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by ERBB2—STUB1—attention deficit hyperactivity disorder	0.00479	0.0163	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.00471	0.016	CbGpPWpGaD
Vemurafenib—BRAF—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00399	0.0135	CbGpPWpGaD
Vemurafenib—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00378	0.0128	CbGpPWpGaD
Vemurafenib—RAF1—SHP2 signaling—BDNF—attention deficit hyperactivity disorder	0.00377	0.0128	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00364	0.0124	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.00361	0.0123	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00349	0.0118	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00323	0.011	CbGpPWpGaD
Vemurafenib—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00302	0.0103	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.003	0.0102	CbGpPWpGaD
Vemurafenib—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00291	0.0099	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00279	0.00946	CbGpPWpGaD
Vemurafenib—RAF1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.00276	0.00937	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00267	0.00907	CbGpPWpGaD
Vemurafenib—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00256	0.00869	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—RTN4—attention deficit hyperactivity disorder	0.00252	0.00856	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00248	0.00843	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00241	0.00819	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—ANK3—attention deficit hyperactivity disorder	0.00233	0.0079	CbGpPWpGaD
Vemurafenib—BRAF—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.00233	0.0079	CbGpPWpGaD
Vemurafenib—RAF1—Insulin Signaling—SNAP25—attention deficit hyperactivity disorder	0.0023	0.00783	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.0023	0.0078	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00226	0.00766	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.00215	0.00732	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00214	0.00725	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00211	0.00717	CbGpPWpGaD
Vemurafenib—BRAF—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.0021	0.00712	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00207	0.00704	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00203	0.00691	CbGpPWpGaD
Vemurafenib—RAF1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00203	0.0069	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00202	0.00685	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00194	0.00659	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.00193	0.00655	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00192	0.00653	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0019	0.00646	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.00185	0.00628	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00185	0.00628	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00182	0.00618	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MB21D1—attention deficit hyperactivity disorder	0.0018	0.00611	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00177	0.00603	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00174	0.0059	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00172	0.00584	CbGpPWpGaD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00169	0.00575	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00169	0.00575	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—STUB1—attention deficit hyperactivity disorder	0.00167	0.00568	CbGpPWpGaD
Vemurafenib—RAF1—Kit receptor signaling pathway—EP300—attention deficit hyperactivity disorder	0.00166	0.00565	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00166	0.00565	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—ANK3—attention deficit hyperactivity disorder	0.00166	0.00564	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—CACNB2—attention deficit hyperactivity disorder	0.00164	0.00557	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00162	0.0055	CbGpPWpGaD
Vemurafenib—RAF1—MAPK Signaling Pathway—BDNF—attention deficit hyperactivity disorder	0.00161	0.00547	CbGpPWpGaD
Vemurafenib—BRAF—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00161	0.00546	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00159	0.0054	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of retinoblastoma protein—EP300—attention deficit hyperactivity disorder	0.00152	0.00517	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—CACNA1C—attention deficit hyperactivity disorder	0.0015	0.00509	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00148	0.00502	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.00146	0.00496	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00145	0.00493	CbGpPWpGaD
Vemurafenib—RAF1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00145	0.00493	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00142	0.00483	CbGpPWpGaD
Vemurafenib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00137	0.00465	CbGpPWpGaD
Vemurafenib—BRAF—Disease—STUB1—attention deficit hyperactivity disorder	0.00135	0.0046	CbGpPWpGaD
Vemurafenib—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00133	0.00451	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—POLR3A—attention deficit hyperactivity disorder	0.00132	0.00448	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00132	0.00447	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways in Glioblastoma—EP300—attention deficit hyperactivity disorder	0.00128	0.00434	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00121	0.00413	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CACNB2—attention deficit hyperactivity disorder	0.00117	0.00397	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00116	0.00394	CbGpPWpGaD
Vemurafenib—BRAF—Integrated Breast Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00113	0.00385	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.00112	0.0038	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00112	0.00379	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00111	0.00378	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00109	0.00372	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—CACNA1C—attention deficit hyperactivity disorder	0.00107	0.00363	CbGpPWpGaD
Vemurafenib—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00106	0.0036	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MB21D1—attention deficit hyperactivity disorder	0.00105	0.00356	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00104	0.00355	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STUB1—attention deficit hyperactivity disorder	0.00101	0.00345	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000954	0.00324	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000948	0.00322	CbGpPWpGaD
Vemurafenib—RAF1—Disease—STUB1—attention deficit hyperactivity disorder	0.000937	0.00318	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000935	0.00317	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000929	0.00315	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000912	0.0031	CbGpPWpGaD
Vemurafenib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000895	0.00304	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000895	0.00304	CbGpPWpGaD
Vemurafenib—RAF1—TGF-beta Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.000874	0.00297	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000873	0.00297	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00084	0.00285	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000815	0.00277	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000798	0.00271	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000783	0.00266	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—POLR3A—attention deficit hyperactivity disorder	0.000769	0.00261	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.000764	0.0026	CbGpPWpGaD
Vemurafenib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.000764	0.0026	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.00075	0.00255	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000733	0.00249	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000727	0.00247	CbGpPWpGaD
Vemurafenib—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000722	0.00245	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000708	0.0024	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000702	0.00238	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000668	0.00227	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000656	0.00223	CbGpPWpGaD
Vemurafenib—RAF1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.00065	0.00221	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000648	0.0022	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SNAP25—attention deficit hyperactivity disorder	0.000642	0.00218	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000621	0.00211	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000617	0.0021	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000616	0.00209	CbGpPWpGaD
Vemurafenib—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000612	0.00208	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000588	0.002	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000566	0.00192	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000564	0.00191	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000553	0.00188	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000552	0.00188	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000542	0.00184	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000527	0.00179	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00051	0.00173	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000501	0.0017	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000495	0.00168	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000484	0.00164	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000479	0.00163	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000476	0.00162	CbGpPWpGaD
Vemurafenib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000472	0.0016	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00047	0.0016	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000461	0.00157	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000461	0.00157	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000461	0.00157	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000454	0.00154	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00045	0.00153	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000444	0.00151	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.00044	0.0015	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000435	0.00148	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000428	0.00145	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000423	0.00144	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000422	0.00143	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000406	0.00138	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000406	0.00138	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000399	0.00136	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000394	0.00134	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000383	0.0013	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000381	0.00129	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000371	0.00126	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000369	0.00125	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000363	0.00123	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000351	0.00119	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000335	0.00114	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000324	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000323	0.0011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000311	0.00106	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000309	0.00105	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000304	0.00103	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000301	0.00102	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0003	0.00102	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000298	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000296	0.00101	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000292	0.000993	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000279	0.000949	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000277	0.000942	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000276	0.000937	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000272	0.000925	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000269	0.000914	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000268	0.000912	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000254	0.000862	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00025	0.000851	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00025	0.000851	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000246	0.000837	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000246	0.000835	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000244	0.000829	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000229	0.000778	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EP300—attention deficit hyperactivity disorder	0.000209	0.000709	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000207	0.000702	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000207	0.000702	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000203	0.000691	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.0002	0.00068	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000196	0.000665	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000191	0.000648	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.000647	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000189	0.000642	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000175	0.000595	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000175	0.000595	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000172	0.000585	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000165	0.000561	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	0.00016	0.000545	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00016	0.000544	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000157	0.000534	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EP300—attention deficit hyperactivity disorder	0.000156	0.000531	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	0.000152	0.000515	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000151	0.000512	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000146	0.000496	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000146	0.000496	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EP300—attention deficit hyperactivity disorder	0.000144	0.00049	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	0.000143	0.000486	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00014	0.000476	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000135	0.000459	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000135	0.000459	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000133	0.000453	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000133	0.000452	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000125	0.000425	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000124	0.000422	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000124	0.00042	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	0.00012	0.000407	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000108	0.000367	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000106	0.00036	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000105	0.000358	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000105	0.000358	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000103	0.000349	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000102	0.000347	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000101	0.000343	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.19e-05	0.000278	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	8.13e-05	0.000276	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	6.51e-05	0.000221	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.37e-05	0.000182	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.55e-05	0.000155	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.51e-05	0.000119	CbGpPWpGaD
